Subscribe for the newsletter
Mobile Navigation
Subscribe for the Newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
PH-HFpEF Patients
Sort By
Newest First
Sign in
1 / 1
1 / 1
Phase 2 Trial
Tenax Therapeutics Announces Study Design for Phase 2 Trial of Levosimendan in PH-HFpEF Patients
Tenax Therapeutics
PR-M06-18-NI-027
Jun 08, 2018
